MedPath

SiteOne Therapeutics, Inc.

SiteOne Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2010-01-01
Employees
1
Market Cap
-
Website
http://www.siteonetherapeutics.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427

Phase 1
Terminated
Conditions
Acute, Post-operative Pain
Interventions
Drug: Placebo
First Posted Date
2020-07-17
Last Posted Date
2023-08-03
Lead Sponsor
SiteOne Therapeutics, Inc.
Target Recruit Count
24
Registration Number
NCT04475198
Locations
🇺🇸

Altasciences, Overland Park, Kansas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.